| Literature DB >> 24053628 |
Silvia Iacobelli1, Benoit Colomb, Francesco Bonsante, Karine Astruc, Cyril Ferdynus, Marie-France Bouthet, Catherine Neuwirth, Ludwig Serge Aho Glélé, Pascal Chavanet, Jean-Bernard Gouyon.
Abstract
BACKGROUND: Aim of this study was to provide a detailed description of a Methicillin-resistant Staphylococcus aureus (MRSA) outbreak management strategy in the neonatal intensive care unit of a university hospital.Entities:
Mesh:
Year: 2013 PMID: 24053628 PMCID: PMC3849690 DOI: 10.1186/1471-2334-13-440
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Management strategic axis and actions retained by the steering committee
| Quality process implementation | Operational team: |
| 1. Care quality improvement approach | |
| 2. Identification of 4 “quality control nurses” among the staff nurses | |
| 3. Definition of desired outcomes | |
| 4. Procedure reference tool validation | |
| 5. Random observation of procedure compliance | |
| 6. Procedure compliance evaluation by a computerized feedback tool | |
| Hospital Hygiene Division: | |
| 7. Hygiene counselling and infections epidemiologic monitoring | |
| Hospital Executive Board: | |
| 8. Bioengineer consultant recruitment | |
| All HCW and visitors: | |
| 9. Anonymous “at risk for infection event” declaration | |
| Effective communication | Head of the paediatric department: |
| 10. Regular reports on MRSA infections management to the hospital executive board, health care branch, department of health quality safety and patient experience | |
| 11. External audit request | |
| Operational team: | |
| 12. Monthly internal feedback audits | |
| 13. Monthly report display in units | |
| Infections epidemiologic monitoring | Staff nurses: |
| 14. Routine weekly MRSA screening | |
| Physicians: | |
| 15. Retrospective and prospective data collection | |
| Hospital Hygiene Division: | |
| 16. Case–control study to identify risk factors for MRSA infections in hospitalized newborns | |
| 17. Regular environmental and medical device cultures | |
| Department of bacteriology: | |
| 18. MRSA clinical isolates genotyping | |
| Hand-hygiene, contact precautions, HCW and patients families clothing and flow issues improvement | Hospital Hygiene Division: |
| 19. Intensive HCW, families and visitors information and training | |
| 20. HCW, families and visitors work clothing + protective clothing implementation | |
| 21. Reinforced barrier precautions for MRSA colonization | |
| 22. Posted isolation cards | |
| Standardisation of procedures for the insertion and the continuous care of peripherally inserted central venous catheters, care of invasive medical devices | Staff nurses: |
| 23. Central venous lines insertion and care checklist | |
| 24. Invasive medical devices care checklist | |
| Units cleaning | Cleaning staff: |
| 25. Cleaning procedure implementation | |
| 26. Cleaning procedure assessment | |
| 27. Cleaning checklist | |
| 28. Cleaning staff overwork lowering (2 recruitments) | |
| 29. Room cleaning intensification (3 daily cleanings versus 1) | |
| 30. Standardized disinfection of external medical devices |
Figure 1Timing of all the interventions during the study period in relation to Methicillin-resistant (MRSA) cases.
Demographic data and perinatal risk factors for hospital acquired infections in the study population
| | |||
|---|---|---|---|
| Gestational age (weeks) | 32.7 ± 4.2 | 33.0 ± 4.5 | 0.31 |
| < 34 (%) | 58.6 | 55.6 | 0.17 |
| 34 - 36 (%) | 20.0 | 18.0 | |
| > 36 (%) | 21.4 | 26.4 | |
| Birth weight (grams) | 1934 ± 864 | 2022 ± 942 | 0.12 |
| Sex male (%) | 56.1 | 54.9 | 0.69 |
| Antenatal steroids (%) | 56.7 | 54.1 | 0.37 |
| Clinical chorioamnionitis (%) | 13.1 | 10.1 | 0.13 |
| Apgar score ≤ 3 at 1 min (%) | 12.7 | 12.1 | 0.17 |
| Inborn (%) | 71.8 | 71.3 | 0.87 |
| Caesarean delivery (%) | 62.3 | 54.3 | 0.0089 |
| Use of surfactant (at last once) (%) | 55.7 | 43.2 | <0.001 |
| Respiratory Distress Syndrome (%) | 79.8 | 78.2 | 0.53 |
| BPD @ 28 days (%) | 17.6 | 19.4 | 0.47 |
| IVH 3°- 4° (%) | 3.1 | 2.4 | 0.33 |
| NEC all stages (%) | 3.3 | 2.8 | 0.60 |
| Malformations (%) | 15.9 | 19.2 | 0.16 |
| Mean duration of stay in III level NICU (days) | 16.8 ± 21.2 | 15.0 ± 19.6 | 0.08 |
| Mean total duration of stay (days) | 47.0 ± 35.3 | 48.4 ± 40.3 | 0.94 |
| Death (%) | 5.9 | 5.4 | 0.71 |
| IMV (% of infants per day) | 0.23 ± 0.09 | 0.18 ± 0.09 | 0.0001 |
| NCPAP (% of infants per day) | 0.49 ± 0.11 | 0.42 ± 0.12 | 0.0001 |
| CVL (% of infants per day) | 0.36 ± 0.13 | 0.34 ± 0.11 | 0.15 |
| Means number of antibiotics (per infant per day) | 0.48 ± 0.22 | 0.53 ± 0.23 | 0.001 |
| Occupancy rate (per day) | 0.87 ± 0.09 | 0.77 ± 0.11 | < 0.0001 |
| Nurse to patient ratio (per day) | 1.35 ± 0.19 | 1.53 ± 0.30 | < 0.0001 |
Abbreviations: BPD Bronchopulmonary Dysplasia, IVH Intraventricular Haemorrhage, NEC Necrotizing Enterocolitis, NICU Neonatal Intensive Care Unit, IMV Invasive Mechanical Ventilation, NCPAP Nasal Continuous Positive Air Pressure, CVC Central Venous Lines.
Figure 2Rates of Methicillin-resistant (MRSA) infections before and after the outbreak management strategy implemented at month 19. On the x axis, time (months); on the y axis, rate of MRSA infection (number for 1000 patient-days).
Laboratory-confirmed bloodstream infections (total cases) throughout the study period
| | |||
|---|---|---|---|
| Positive laboratory-confirmed blood culture | 160 | 83 | < 0.0001 |
| MRSA | 25 | 5 | 0.0002 |
| 115 | 70 | 0.0003 | |
| “Other gram positive” pathogens | 9 | 5 | 0.29 |
| Gram negative pathogens | 11 | 3 | 0.03 |
Figure 3Decline of Methicillin-resistant (MRSA) colonization rate over the second period of the study. On the x axis, time (months); on the y axis, rate of MRSA colonization (number for 1000 patient-days).